Novo Nordisk A/S News Headlines

NVO 
$45.44
*  
0.68
1.47%
Get NVO Alerts
*Delayed - data as of Jul. 24, 2014 13:29 ET  -  Find a broker to begin trading NVO now
Exchange: NYSE
Industry: Health Care
Community Rating:
View:    NVO Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Positive News for AstraZeneca - Analyst Blog
9/17/2013 4:45:01 PM - Zacks.com

Verdict on Glaxo's Lovaza - Analyst Blog
9/17/2013 10:58:45 AM - Zacks.com

Another Indication for Allergan's Botox - Analyst Blog
9/16/2013 4:58:40 PM - Zacks.com

Glaxo Reports Positive Data - Analyst Blog
9/16/2013 12:58:06 PM - Zacks.com

European Shares Rally After Summers Pulls Out of Running for Fed Chief, US and Russia Agree on Syria Deal
9/16/2013 12:14:12 PM - MT Newswires

Lixisenatide NDA Withdrawn by Sanofi - Analyst Blog
9/13/2013 10:58:15 AM - Zacks.com

Update on J&J/Genmab's Daratumumab - Analyst Blog
9/12/2013 12:57:53 PM - Zacks.com

AstraZeneca, Merck Ink Licensing Deal - Analyst Blog
9/12/2013 11:40:01 AM - Zacks.com

Another Prize Slips Through Novo's Hands As Big PBM Looks Elsewhere
9/4/2013 1:38:00 PM - Seeking Alpha

AstraZeneca Reports Onglyza Data - Analyst Blog
9/3/2013 5:30:01 PM - Zacks.com

Positive Data on Takeda's AlogliptIn - Analyst Blog
9/3/2013 4:35:01 PM - Zacks.com

Considering High-DGR Dividend Growth Stocks
9/3/2013 11:49:00 AM - Seeking Alpha

Jim Simons Buys Apple, Citigroup, McDonald's, Sells Google, PepsiCo, IBM
8/13/2013 9:54:44 AM - GuruFocus

Novo Nordisk Beats on Earnings & Sales - Analyst Blog
8/12/2013 1:35:46 PM - Zacks.com

Novo Nordisk Getting Its Trial By Fire
8/8/2013 4:00:00 PM - Investopedia

Approval Delayed for Glaxo Drug - Analyst Blog
8/6/2013 5:40:54 PM - Zacks.com

Rexahn's CEO Uses A Business-Driven Cancer Model For Shareholder Value
8/5/2013 6:34:00 PM - Seeking Alpha

Oramed Expands Diabetes Platform With Oral GLP-1 Agonist
8/5/2013 4:29:00 PM - Seeking Alpha

5 Upcoming Dividend Aristocrats You May Be Looking Past
7/23/2013 11:12:00 AM - Seeking Alpha

Merck's $5.7 Billion Diabetes Franchise Is Vulnerable
7/10/2013 9:44:00 AM - Seeking Alpha

Bayer Initiates Phase III Study - Analyst Blog
7/9/2013 6:05:01 PM - Zacks.com

Glaxo Initiates Phase III Study - Analyst Blog
7/8/2013 5:07:26 PM - Zacks.com

Bayer Announces Positive Phase I Data - Analyst Blog
7/8/2013 5:00:01 PM - Zacks.com

Label Expansion for Novartis' Lucentis - Analyst Blog
7/5/2013 5:05:01 PM - Zacks.com

Priority Review for Roche Candidate - Analyst Blog
7/5/2013 4:38:36 PM - Zacks.com